Pooling signaling and costimulatory domains in B7H6 chimeric antigen receptor

GENE REGULATION VIA CONDITIONAL NUCLEAR LOCALIZATION OF GENE MODULATING POLYPEPTIDES

RECOMBINANT GLUT1 ADENO-ASSOCIATED VIRAL VECTOR CONSTRUCTS AND RELATED METHODS FOR RESTORING GLUT1 EXPRESSION

Chimeric proteins and methods of regulating gene expression

Synthetic notch receptor protein for modulating gene expression

Diagnostic kit

Protease-activated receptor-2 modulators

HIGH AFFINITY NY-ESO T CELL RECEPTORS

Chimeric antigen receptors and methods of use thereof

CLAUDIN-6 PEPTIDES

COMPOSITIONS AND METHODS FOR NEUROLOGICAL DISEASES

Primate retinal pigment epithelium cell-specific promoter

PEPTIDES

Compositions and methods to modulate cell activity

METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

METHOD FOR TREATING GLIOBLASTOMA

Method for Stimulating the Gene Expression in Endometrial Cells

Materials and methods for improved single chain variable fragments

Methods for reducing CD36 expression

Anti-TIGIT antibody and use thereof

CD137 binding fibronectin type III domains

Composition and Use of Humoral Immune Suppressor Antagonists for the Treatment of Humoral Immune Suppressed Diseases

ANTIBODIES TO MICA AND MICB PROTEINS

Targeted delivery of glycine receptors to excitable cells

COMBINATION THERAPY USING A CHIMERIC ANTIGEN RECEPTOR

Mutations in rhodopsin gene in zebrafish and uses thereof

MODULATING T CELL FUNCTION AND RESPONSE

Target recognition motifs and uses thereof

PD-L1 binding fibronectin type III domains

EXPRESSION VECTORS FOR CHIMERIC ENGULFMENT RECEPTORS, GENETICALLY MODIFIED HOST CELLS, AND USES THEREOF

NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

ANTIGEN TREATMENT METHOD

RECOMBINANT VIRAL VECTOR AND USES THEREOF

Rescuing voltage-gated sodium channel function in inhibitory neurons

Modification of immune cells for reducing toxicity and uses thereof in adoptive cell therapy

Use of ICOS-based cars to enhance antitumor activity and car persistence

METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTORS AND ADAPTORS THEREOF

Expression vectors comprising engineered genes

Tumor marker, and method for collecting and detecting tumor cell in distinction from contaminant cell

Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy

Activin receptor type IIB variants and methods of use thereof

EGF(A) ANALOGUES WITH FATTY ACID SUBSTITUENTS

ETANERCEPT FORMULATIONS STABILIZED WITH XYLITOL

FhuD2 fusion proteins for the outer membrane vesicle (OMV) delivery of heterologous polypetides and immunogenic compositions thereof

ALK polypeptides and methods of use thereof

FUSION POLYPEPTIDE

Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same

FUSION IMMUNOMODULATORY PROTEINS AND METHODS FOR MAKING SAME

TIGIT- and light-based chimeric proteins

Compbody—a multivalent target binder

Engineered DNA binding proteins

IL-18 binding protein (IL-18BP) in inflammatory diseases

Methods of treating cancer

Modifiers of CFTR-directed therapy

Use of chimeric antigen receptor modified cells to treat cancer

Antibodies to L-type voltage gated channels and related methods

Chloride salt of TAT-NR2B9C

Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases

IMMUNE CELLS WITH MODIFIED METABOLISM AND THEIR USE THEREOF

GENE THERAPY TO IMPROVE VISION

Induction and enhancement of antitumor immunity involving virus vectors expressing multiple epitopes of tumor associated antigens and immune checkpoint inhibitors or proteins

Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

Modified ligand-gated ion channels and methods of use

ORGANIC COMPOUNDS

MRGPRX2/MRGPRB2 EXPRESSING CELL BASED ASSAY TO DETECT PSEUDO-ALLERGIC DRUG REACTIONS AND TO IDENTIFY BLOCKERS TO PREVENT THE ADVERSE REACTIONS

Compounds that modulate the interaction of VISTA and VSIG3 and methods of making and using

NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF

Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases

Loss of function mutations in cause SeSAME, a human syndrome with sensory, neurological, and renal deficits

EPHA3 and multi-valent targeting of tumors

COMPOSITIONS OF ENGINEERED EXOSOMES AND METHODS OF LOADING LUMINAL EXOSOMES PAY-LOADS

USES OF AMPHIPHILES IN IMMUNE CELL THERAPY AND COMPOSITIONS THEREFOR

Protease-resistant systems for polypeptide display and methods of making and using thereof

Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods

Compositions and methods for selective protein degradation

ANTIBODIES FOR MODULATING BINDING BETWEEN LRP AND WISE

CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALLING SYSTEM

Adenocarcinoma detection method

IMMORTALIZED CAR-T CELLS GENETICALLY MODIFIED TO ELIMINATE T-CELL RECEPTOR AND BETA 2-MICROGLOBULIN EXPRESSION

Force sensor cleavage domain containing chimeric polypeptides and methods of use thereof

Therapeutic agents

METHOD FOR MODULATING INSULIN-INDEPENDENT GLUCOSE TRANSPORT USING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE (TCAP)

Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor

Vesicular stomatitis viruses

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Compositions and methods for immunotherapy

TARGETED AND MODULAR EXOSOME LOADING SYSTEM

Cell surface conjugates and related cell compositions and methods

NEW ONCO-IMMUNOLOGIC PROGNOSTIC AND THERANOSTIC MARKERS

Composition for delivery of genetic material

Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof

AFFINITY-TAGGED PHOTOSWITCHES AND METHODS OF USE THEREOF

Diagnosis and therapy of multiple sclerosis

PROPROTEINS AND METHODS OF USE THEREOF

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

METHODS AND COMPOSITIONS ENHANCING SURVIVAL AND FUNCTIONALITY OF ANTI-TUMOR AND ANTI-VIRAL T CELLS

Thymic epithelial cells, exosomes derived therefrom, and methods of making and using same

ROR1 antibody compositions and related methods

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

Cell

Methods and compositions for diagnosing and treating diseases

Chimeric antigen receptors, compositions, and methods

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Compositions containing protein loaded exosome and methods for preparing and delivering the same

METHODS OF TREATING METASTATIC CANCERS USING AXL DECOY RECEPTORS

Method of assessing ABC transporter activity using fluorescent dye accumulation assay

ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR

TIGIT- and light-based chimeric proteins

Chimeric endocytic receptors and method of use thereof

Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins

Therapeutic agents

Immunotherapeutic method for treating lung cancer by administering a polypeptide comprising an epitope of hZP3

Nanovesicle comprising heterodimeric G-protein coupled receptor, method for preparing nanovesicle, field effect transistor-based taste sensor comprising nanovesicle, and method for manufacturing taste sensor

Compositions and methods for treating cancer

ANTIGEN BINDING MOLECULES COMPRISING A TRIMERIC TNF FAMILY LIGAND

Rodents having genetically modified sodium channels and methods of use thereof

Succinate-binding polypeptides and use thereof

Transgenic Insect and Use of Same in Methods for Testing Natural or Synthetic Substances

Tagged chimeric effector molecules and receptors thereof

T cell receptors and immune therapy using the same

THERAPEUTIC TREM-1 PEPTIDES

NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME

TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF

Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors

CONSUMABLE CRYOPRESERVED CELLS TRANSIENTLY OVEREXPRESSING GENE(S) ENCODING DRUG TRANSPORTER PROTEIN(S) AND/OR DRUG METABOLIZING ENZYME(S)

CONSUMABLE CRYOPRESERVED CELLS TRANSIENTLY OVEREXPRESSING GENE(S) ENCODING DRUG TRANSPORTER PROTEIN(S) AND/OR DRUG METABOLIZING ENZYME(S)

Glucose transporter inhibitor-modified insulin for glucose-responsive insulin delivery

Binding domains directed against GPCR:G protein complexes and uses derived thereof

Chimeric antigen receptor and methods of use thereof

Compositions comprising G protein-coupled receptors maintained in a conformationally selective manner by a modulator

T-cells expressing anti-LIV1 chimeric antigen receptor

GPR156 variants and uses thereof

Exosome production method

Gene therapy for treating familial hypercholesterolemia

Gene-modified mouse expressing human GPC3 polypeptide

EXPRESSION SYSTEMS THAT FACILITATE NUCLEIC ACID DELIVERY AND METHODS OF USE

Preparation of therapeutic exosomes using membrane proteins

Methods of making and using extracellular domain-based chimeric proteins

Chimeric protein

Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody

Generalized Extracellular Molecule Sensor

Fusion protein

COMPOSITIONS AND METHODS FOR PRODUCING EXOSOME LOADED THERAPEUTICS FOR THE TREATMENT OF MULTIPLE ONCOLOGICAL DISORDERS

ANTI-TAU CONSTRUCTS

Therapeutic delivery vesicles

EXOSOMES FOR TARGET SPECIFIC DELIVERY AND METHODS FOR PREPARING AND DELIVERING THE SAME

STEM CELL DELIVERED ONCOLYTIC HERPES SIMPLEX VIRUS AND METHODS FOR TREATING BRAIN TUMORS

Compositions and Methods for Cancer Immunotherapy

Mouse with cholinergic neuron-specific inactivated ANO1 gene

Cancer antigen targets and uses thereof

Recombinant cardiomyocytes and cardiomyocyte cell lines expressing hERG

ENGINEERED T-CELL MODULATING MOLECULES AND METHODS OF USING SAME

Recombinant klotho proteins and compositions and methods involving same

MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same

WATER-SOLUBLE TRANS-MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF

Configuring a Smart Home Controller

Multimeric coding nucleic acid and uses thereof

Compositions and methods for inducing scarring by peri-tumoral cells

CATIONIC NUCLEIC ACID SCAVENGER AND USES THEREOF

BRAIN SPECIFIC EXOSOME BASED DIAGNOSTICS AND EXTRACORPOREAL THERAPIES

Modulation of the notch signaling pathway for treatment of respiratory disorders

ENDOTHELIAL-SPECIFIC PROMOTER SEQUENCES AND USES THEREOF

TISSUE SELECTIVE TRANSGENE EXPRESSION

Therapeutic use of inhibitors of t cell activation or stimulation

Resolvin mimetic antibodies and uses thereof

Methods of using an antibody to stabilize and analyze a BRIL fusion protein

NOVEL THERAPEUTIC ENZYME FUSION PROTEIN AND USE THEREOF

Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR

TRPC3 as a therapeutic target for alzheimer's disease

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Peptide for toll-like receptor (TLR) inhibition and pharmaceutical composition comprising same

Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereof

Non-natural NKG2D receptors that do not directly signal the cells to which they are attached

Targeted gene therapies for pain and other neuro-related disorders

NOVEL PEPTIDES AND PEPTIDOMIMETICS

COMPOSITIONS AND METHODS RELATED TO ENGINEERED ERYTHROID CELLS COMPRISING IL-15

Detection of co-occurring receptor-coding nucleic acid segments

Optogenetic probes for measuring membrane potential

Chimeric NK receptor and methods for treating cancer

PANCREATIC CANCER TARGETS AND USES THEREOF

Treatment of fibrodysplasia ossificans progressiva

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

Anti-TMEFF1 antibodies and antibody drug conjugates

Extracellular vesicle comprising a fusion protein having Fc binding capacity

Radiotherapeutic and companion imaging agents to target MC1R

NOTCH3 agonist compositions and methods for treating small vessel diseases

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Agents that modulate immune cell activation and methods of use thereof

Peptides and combination of peptides for use in immunotherapy against various cancers

URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME

INTERACTION BETWEEN C-PEPTIDES AND ELASTIN RECEPTOR, A MODEL FOR UNDERSTANDING VASCULAR DISEASE

Recombinant vector comprising porcine FC fragment and preparation method of recombinant protein using thereof

Dendrimer conjugates for coating cells

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif

Antigen fused with porcine Fc fragment and vaccine composition comprising the same

Chimeric antigen receptors and methods of use

Method and compositions for cellular immunotherapy

CHIMERIC PROTEINS AND METHODS OF REGULATING GENE EXPRESSION

Genetically modified genes and cells, and methods of using same for silencing virus gene expression

ANTIBODIES TO NON-FUNCTIONAL P2X7 RECEPTOR

VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR

In vitro production of red blood cells with proteins comprising sortase recognition motifs

Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereof

OPTOGENETIC THERAPEUTIC AND METHOD OF TREATING RETINAL DEGENERATIVE AND NEURODEGENERATIVE DISEASES

Soluble CD33 for treating myelodysplastic syndromes (MDS)

Antitumor peptide having PD-1 signal sequence and utilization thereof

MRNA combination therapy for the treatment of cancer

Breast and ovarian cancer vaccines

INTEGRATION OF MESA RECEPTORS AND PROMOTORS TO IMPLEMENT CUSTOMIZED CELLULAR FUNCTION

Modified immunoglobulin hinge regions to reduce hemagglutination

Recombinant factor VIII proteins

Tissue-specific Wnt signal enhancing molecules and uses thereof

CFTR MRNA compositions and related methods and uses

FIBROBLAST GROWTH FACTOR (FGF) 1 WITH MUTATION IN THE HEPARIN BINDING DOMAIN AND METHODS OF USE TO REDUCE BLOOD GLUCOSE

PSMA-specific binding proteins

T2R Taste Receptors and Genes Encoding Same

PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF

TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN

Gene therapy for the treatment of CNGB1-linked retinitis pigmentosa

Malaria vaccine and methods for producing same

Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof

TRPC6 involved in glomerulonephritis

Stable VAMP reporter assay

CACNA1H-derived tumor antigen polypeptide and use thereof

In situ lipid synthesis for protein reconstitution

Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma

Compositions and methods for regulating blood pressure

Methods related to engineered erythoid cells comprising 4-1BBL

NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF

Fusion proteins containing luciferase and a polypeptide of interest

Transgenic macrophages, chimeric antigen receptors, and associated methods

Method of identifying malodor modulating compounds

Peptides and combination of peptides for use in immunotherapy against various cancers

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

Multifunctional heteromultimeric constructs

Norbornene-based amphipathic compound and utilization thereof

Botulinum neurotoxins with modified light chain specificity and methods for producing same

Compositions and Methods for Cancer Immunotherapy

Methods of Genetic Modification of a Cell

Modified ligand-gated ion channels and methods of use

Kv1.3 potassium channel antagonists

RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE

TIGIT- AND LIGHT-BASED CHIMERIC PROTEINS

Methods for increasing palatability of pet foodstuff

TREATMENT OF DIABETES, TOLL-LIKE RECEPTOR 4 MODULATORS AND METHODS FOR USING THE SAME

S-layer protein 2D lattice coupled detergent-free GPCR bioelectronic interfaces, devices, and methods for the use thereof

ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS

Use of the CD2 signaling domain in second-generation chimeric antigen receptors

IDENTIFICATION OF NOVEL ANTI-FIBROTIC PEPTIDE IN C-TERMINAL REGION OF THE MET RECEPTOR TYROSINE KINASE

Cancer treatment using CX26 blocking peptides

Materials and methods for delivering nucleic acids to cochlear and vestibular cells

SorCS PEPTIDES AND USES THEREOF

Opioid receptor binding agents and uses thereof

Chimeric NK receptor and methods for treating cancer

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof

Membrane span-kinase fusion protein and the uses thereof

S-Arrestin peptides and therapeutic uses thereof

HV1 modulators and uses

Inhibiting the transient receptor potential A1 ion channel

Cytokine receptor genes and the use thereof to enhance therapy

Colon and pancreas cancer specific antigens and antibodies

T cell receptors and immune therapy using the same

Compositions and methods for enhancement of immune responses

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

Method of Identifying Transmembrane Protein-interacting Compounds

Compositions and methods of chimeric autoantibody receptor T cells

Compositions and methods of chimeric autoantibody receptor T cells

Compositions and methods of chimeric autoantibody receptor T cells

TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch

In vivo production of proteins

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

TREATMENT OF HORMONAL DISORDERS OF GROWTH

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

PROTEINS

Methods and compositions for the treatment of cancer

TLR9-binding chimeric antigen receptors

MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF

Compositions and methods of chimeric autoantibody receptor T cells

Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies

Somatic opsins for single cell resolution optogenetics

Methods for treating bone loss using sclerostin peptides

METHODS FOR OFF-THE-SHELF-TUMOR IMMUNOTHERAPY USING ALLOGENEIC T-CELL PRECURSORS

Method of reducing formation of etanercept aggregates or fragments

METHODS OF ADOPTIVE CELL THERAPY

Therapeutic cell systems and methods for treating cancer and infectious diseases

Repressors of viral infection

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

Stable aqueous etanercept composition